Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.
In a classic case of double trouble, the binding of SARS-CoV-2’s spike protein to bacterial lipopolysaccharide supercharges inflammation in COVID-19 patients.
Lockdown measures not only reduced the number of COVID-19 cases but also resulted in a temporary improvement in air quality, study finds.
Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.
Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.
A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.
By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.
A*STAR researchers use digital drug simulators to predict the efficacies of repurposed antivirals for treating COVID-19.
This ‘smart mask’ designed by A*STAR researchers may reduce the risk of infection in healthcare workers by enabling remote, real-time monitoring of patients’ symptoms.
Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
The presence of memory T cells in COVID-19-recovered patients hints at their importance in COVID-19 immunity.
Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.